Matthias A.
- Country
- Germany
- Department
- Klinik und Poliklinik für Dermatologie, Venerologie und Allergologie
Research Overview
- A Phase 1, Adaptive, First-in-Human Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of SYX-5219 in Healthy Volunteers and Participants with Atopic Dermatitis
- A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Ritlecitinib in Adults with Moderate to Severe Hidradenitis Suppurativa
- Phase 3 Extension Study of Long-Term Safety and Efficacy of Remibrutinib in Adults With Moderate to Severe Hidradenitis Suppurativa
Data & Insights
Has run more than one trial at 296 of 544 partner sites.
Specializations
Inflammatory Skin Conditions
The investigator specializes in treating complex dermatological conditions, with particular focus on hidradenitis suppurativa and plaque psoriasis. Their research encompasses innovative therapeutic approaches for managing chronic inflammatory skin disorders.
- Hidradenitis Suppurativa Management
- Moderate to Severe Plaque Psoriasis
- Novel Biologic Therapies
Chronic Skin Disorders
The investigator focuses on treating persistent skin conditions, including atopic dermatitis and prurigo nodularis. Their work involves evaluating advanced therapeutic options for managing chronic dermatological manifestations.
- Atopic Dermatitis Treatment
- Prurigo Nodularis Management
- Vitiligo Interventions
Specialized Dermatological Conditions
The investigator addresses unique dermatological challenges, including pyoderma gangrenosum and chronic venous ulcers. Their expertise extends to treating alopecia areata in pediatric populations.
- Ulcerative Skin Conditions
- Wound Healing Therapies
- Pediatric Dermatology
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.